- Home
- ZNTL vs CODA Comparison
ZNTL vs CODA Comparison
Compare ZNTL & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- CODA
- Stock Information
- Founded
- ZNTL 2014
- CODA 1994
- Country
- ZNTL United States
- CODA United States
- Employees
- ZNTL N/A
- CODA N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- CODA Industrial Machinery/Components
- Sector
- ZNTL Health Care
- CODA Industrials
- Exchange
- ZNTL Nasdaq
- CODA Nasdaq
- Market Cap
- ZNTL 105.8M
- CODA 88.7M
- IPO Year
- ZNTL 2020
- CODA N/A
- Fundamental
- Price
- ZNTL $1.33
- CODA $8.10
- Analyst Decision
- ZNTL Buy
- CODA Strong Buy
- Analyst Count
- ZNTL 7
- CODA 1
- Target Price
- ZNTL $8.60
- CODA $11.00
- AVG Volume (30 Days)
- ZNTL 1.4M
- CODA 59.6K
- Earning Date
- ZNTL 08-08-2025
- CODA 06-16-2025
- Dividend Yield
- ZNTL N/A
- CODA N/A
- EPS Growth
- ZNTL N/A
- CODA 21.86
- EPS
- ZNTL N/A
- CODA 0.30
- Revenue
- ZNTL $26,865,000.00
- CODA $22,758,966.00
- Revenue This Year
- ZNTL N/A
- CODA $11.64
- Revenue Next Year
- ZNTL N/A
- CODA $14.53
- P/E Ratio
- ZNTL N/A
- CODA $26.83
- Revenue Growth
- ZNTL N/A
- CODA 24.78
- 52 Week Low
- ZNTL $1.01
- CODA $5.76
- 52 Week High
- ZNTL $5.44
- CODA $9.89
- Technical
- Relative Strength Index (RSI)
- ZNTL 50.91
- CODA 57.37
- Support Level
- ZNTL $1.15
- CODA $7.81
- Resistance Level
- ZNTL $1.38
- CODA $8.50
- Average True Range (ATR)
- ZNTL 0.10
- CODA 0.41
- MACD
- ZNTL 0.01
- CODA -0.01
- Stochastic Oscillator
- ZNTL 75.00
- CODA 63.45
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.